In this literature review, we summarize the main therapeutic strategies developed to improve the prognosis of patients with EGFR-mutated NSCLC, reporting the results of the most significant studies as well as the updated data that have been recently presented. Here, EGFR is linked to non-small cell lung carcinoma.